In-hospital care pathways for strokeJoseph Kwan(Southampton General Hospital), Peter Sandercock(University College London)Cochrane Database of Systematic ReviewsOctober 14, 200410.1002/14651858.cd002924.pub2Cited by 145SaveCiteExport RISWatch citationsRelated PapersEffect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials|The Lancet|2014|2.7kInterpretation of the evidence for the efficacy and safety of statin therapy|The Lancet|2016|1.8kThe benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial|The Lancet|2012|1.2kRecombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis|The Lancet|2012|1kComparison of treatment effects between animal experiments and clinical trials: systematic review|BMJ|2006|809